Stockscreener 앱 받기
231.12
0.66%
-1.53
전일 마감가:
$232.65
열려 있는:
$229.43
하루 거래량:
1.54M
Relative Volume:
2.00
시가총액:
$16.63B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
34.62
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
-2.34%
1개월 성능:
-16.52%
6개월 성능:
-7.26%
1년 성능:
-32.80%
1일 변동 폭
$223.83
$232.05
1주일 범위
$223.83
$243.91
52주 변동 폭
$187.43
$347.14
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
231.12 | 16.74B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
504.22 | 179.92B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.48 | 57.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.98 | 39.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.31 | 37.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.20 | 36.39B | 27.43B | 1.27B | 1.01B | 1.5829 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
New York State Common Retirement Fund Has $23.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Valuation Check After Recent Share Price Pressure - Yahoo Finance
Published on: 2026-01-31 17:32:53 - mfd.ru
West Pharmaceutical Services Inc (WST) Shares Gap Down to $225.5 on Jan 30 - GuruFocus
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Kinston marks anniversary of West Pharmaceutical Services explosion - WCTI
West to Host Fourth-Quarter and Full-Year 2025 Conference Call - Finviz
West to Host Fourth-Quarter and Full-Year 2025 Conference Call – Company Announcement - Financial Times
Is West Pharmaceutical Services Inc. a good ESG investmentPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru
West Pharmaceutical Services, Inc. $WST Shares Sold by Bank of New York Mellon Corp - MarketBeat
Process Safety Quiz: Dust Explosions and Fires - ChemistryViews
Prefilled Syringe Barrels Market Set for Dynamic Development - openPR.com
West to sell SmartDose 3.5mL system to AbbVie in $112.5M deal - MSN
Ex-Dividend Reminder: West Pharmaceutical Services, Heritage Financial and Entegris - Nasdaq
Assessing West Pharmaceutical (WST) Valuation After Bullish Earnings Outlook And Demand Strength - Sahm
West Pharmaceutical Services (WST) Stock Analysis: A 46% Upside Potential That Investors Can't Ignore - DirectorsTalk Interviews
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? - Benzinga
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - MyChesCo
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Profit Review: What is Know Labs Incs market positionJuly 2025 Earnings & Weekly High Return Stock Forecasts - baoquankhu1.vn
Is West Pharmaceutical Services Stock Built to Withstand More Downside? - Trefis
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio - Sahm
Analysis Recap: Can AROW grow without external funding2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack - sharewise.com
West Pharmaceutical Services Becomes Oversold (WST) - Nasdaq
Bull Run: Is West Pharmaceutical Services Inc trading at a discountM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Market Outlook: Is West Pharmaceutical Services Inc stock showing strong momentumEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
Performance Recap: Whats the outlook for West Pharmaceutical Services Incs sector2025 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - yourwyominglink.com
All you need to know about West Pharmaceutical (WST) rating upgrade to strong buy - MSN
All You Need to Know About West Pharmaceutical (WST) Rating Upgrade to Strong Buy - Yahoo Finance
West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Is West Pharmaceutical (WST) Quietly Redefining Its Edge Through Integrated Drug‑Device Innovation? - Sahm
Vest Financial LLC Sells 48,353 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Rakuten Investment Management Inc. Takes $24.68 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
United States Vaccine Packaging Market to hit US$ 870 Million - openPR.com
West launches prefillable syringe system at Pharmapack 2026 By Investing.com - Investing.com Australia
West launches prefillable syringe system at Pharmapack 2026 - Investing.com
West Synchrony S1 Prefillable Syringe System Commercially Available at Pharmapack - Finviz
West Pharmaceutical Launches New Prefillable Syringe System to Enhance Drug Delivery - Intellectia AI
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack – Company Announcement - Financial Times
New prefilled syringe system targets biologic and vaccine delivery - Stock Titan
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities - Yahoo Finance
Aug Breakouts: Is West Pharmaceutical Services Inc stock showing strong momentumJuly 2025 Outlook & Verified Chart Pattern Trade Signals - baoquankhu1.vn
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
1.26%
자본화:
|
볼륨(24시간):